SecBot SecBot
8-K ·Filed May 8, 2026

BKHAU

Black Hawk Acquisition Corp
NEUTRAL
Impact 2/10
Horizonweeks Processed5mo ago SEC0001829126-26-004870
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight • Neutral

Monitor for any DeSPAC announcement or additional financing needs. The small loan size relative to trust proceeds suggests no near-term liquidity risk; the conversion terms are favorable to the sponsor.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
BKHAU ▲ +3.88% at T+60d
NEUTRAL call +3.88% · α vs SPY -0.51% · entry $11.60 → $12.05
Entry = T+0 close
May 8, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.14%
$11.60
settled 6mo ago
T+5d
+2.59%
call +2.59% · α +2.67%
$11.90
settled 6mo ago
T+20d
+26.64%
call +26.64% · α +26.94%
$14.69
settled 5mo ago
T+60d
+3.88%
call +3.88% · α -0.51%
$12.05
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Black Hawk Acquisition Corp., a SPAC, issued a convertible promissory note to its sponsor for up to $300,000 at 10% interest, primarily for working capital and extension purposes. The note matures upon a business combination or liquidation and may convert at $1.00 per share, with the sponsor waiving claims against the trust account. This routine financing keeps the SPAC operational and does not indicate distress.

Key Financial Metrics

Offering Size
$300.0K

Key Facts

  • Convertible note issued to sponsor for up to $300,000 at 10% interest
  • Mature upon a DeSPAC transaction or liquidation; sponsor can elect cash or conversion at $1.00/share
  • Sponsor waived any claim against the trust account; note is unsecured
  • Proceeds for working capital and extension purposes

Financial Impact

Up to $300,000 in additional debt at 10% interest; conversion at $1.00/share would dilute existing shareholders if converted, but only upon a business combination

debtdilution

Risk Factors

  • If no business combination occurs, SPAC may liquidate and the note is repaid in cash from trust? But trust waiver means sponsor bears risk, not shareholders
  • Potential dilution upon conversion if note is converted at $1.00/share, significantly below trust value

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001829126-26-004870
Document: blackhawkacq_8k.htm0001829126-26-004870
Document: 0001829126-26-004870-index-headers.html0001829126-26-004870
Document: 0001829126-26-004870-index.html0001829126-26-004870
Document: 0001829126-26-004870.txt0001829126-26-004870
2 reports for BKHAU
Performance horizon
Filters
Rows
Reports for BKHAU — sortable, filterable
TypeNow
May 8, 2026
24w ago
8-K
NEUTRAL ★ 2/10
$11.60 $14.69▲ +26.64%▲ +26.94%$5.24 (−54.83%)
Mar 18, 2026
31w ago
Press Release
NEUTRAL ★ 4/10
$11.69 $11.69· 0.00%▼ −7.62%$5.24 (−55.18%)
Showing 2 of 2

US Market Status

Market Closed — Opens in 1h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 8, 2026